Cardlytics (CDLX) IPO Opens 7% Lower
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Tesla acquires AI hardware company for up to $2 billion in stock
- Bel Fuse acquires dataMate ethernet business for $16 million
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
Cardlytics (Nasdaq: CDLX) to Ring The Nasdaq Stock Market Opening Bell in Celebration of its IPO
February 9, 2018 6:00 AM ESTADVISORY, Feb. 09, 2018 (GLOBE NEWSWIRE) --
What:Â Cardlytics (Nasdaq: CDLX), a purchase intelligence platform that helps make marketing more relevant and measurable, will visit the Nasdaq MarketSite in Times Square, in celebration of its initial public offering (IPO).
In honor of the occasion, Scott Grimes, CEO & Co-Founder & Lynne Laube, COO & Co-Founder, will ring the Opening Bell.Â
Where:Nasdaq MarketSite 4 Times Square 43rd & Broadway Broadcast Studio
When:Friday, February 9, 2018 9:15 a.m. to 9:30 a.m. ETÂ Â Â Â
Cardlytics Media... More
Cardlytics Announces Pricing of Initial Public Offering
February 8, 2018 6:41 PM ESTATLANTA, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Cardlytics, Inc., a purchase intelligence platform that helps make marketing more relevant and measurable, today announced the pricing of its initial public offering of 5,400,000 shares of common stock at a price to the public of $13.00 per share, before underwriting discounts and commissions. All of the shares of common stock are being offered by Cardlytics. In addition, Cardlytics has granted the underwriters a 30-day option to purchase up to an additional 810,000 shares of common stock. Cardlytics common stock is expected to begin trading on the Nasdaq Global Market under the ticker symbol CDLX on February 9, 2018. The... More

